Jazz Pharmaceuticals
JAZZ
JAZZ
483 hedge funds and large institutions have $7.32B invested in Jazz Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 161 increasing their positions, 178 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.96% more ownership
Funds ownership: 88.44% → 89.4% (+0.96%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
10% less repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 178
Holders
483
Holding in Top 10
6
Calls
$38.8M
Puts
$14.6M
Top Buyers
| 1 | +$39.8M | |
| 2 | +$35.4M | |
| 3 | +$30.9M | |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$24.8M |
| 5 |
Aristotle Capital Management
Los Angeles,
California
|
+$22.7M |
Top Sellers
| 1 | -$42.4M | |
| 2 | -$40.9M | |
| 3 | -$35.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$25.8M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$24.1M |